Jafron Biomedical Co. Ltd. (300529)
Market Open
10 Aug, 06:57
XSHE XSHE Primary ¥
16. 41
+0.03
+0.1832%
¥
16.2B Market Cap
- P/E Ratio
3.2% Div Yield
16.75M Volume
- Eps
¥ 16.38
Previous Close Want to track 300529 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Jafron Biomedical Co. Ltd. (300529) Statistics
Valuation metrics
Market Cap 16.2B
Enterprise value 13.85B
Trailing P/E (ttm) 22.66
Forward P/E -
PEG ratio -1.04
Price/Sales (ttm) 6.46
Price/Book (mrq) 3.49
Enterprise Value/Revenue 6.84
Enterprise Value/EBITDA 16.17
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.55M
Average volume (90 days) 7.38M
Price summary
52-Week low 14.73
52-Week high 24.66
Beta -
50-Day moving average 16.88
200-Day moving average 18.19
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.52
Trailing annual dividend yield 0.0317%
5-Year annual dividend yield -
Payout ratio 1.14
Dividend Date 1 Jun 2026
Ex-Dividend Date 1 Jun 2026
Last split factor 1:1
Last split Date 20 May 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.28%
Operating margin 0.35%
Operational effectiveness
Return on assets 0.1%
Return on equity 0.16%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.57
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.72
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.34
Total debt (mrq) -
Total Debt/Equity (mrq) 0.34
Current ratio (mrq) 8.71%
Book value per share (mrq) 4.7
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
